| Read Time: < 1 minute | Dangerous Drugs

Research Finds Increased Risk In Pancreatic Cancer

2018:  Researchers compared data from over 33,000 diabetes patients on incretin mimetics with over 525,000 other diabetes patients treated with other medication. They found that patients taking the incretin mimetics had double the risk of developing pancreatic cancer as those taking other medication. Reference:  Boniol, Mathieu, et al. “Incretin-Based Therapies and the Short-Term Risk of Pancreatic Cancer: Results From...

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Johnson & Johnson Sued Over Diabetes Treatment Drug

People who had to get below-the-knee amputations after taking Invokana are filing lawsuits against the drug’s manufacturer, Johnson & Johnson. More than 950 complaints have been filed in New Jersey, Johnson & Johnson’s headquarters. A federal court created a multi-district litigation to combine the complaints. The lawsuits are in conjunction with a black box warning label that the FDA...

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Appellate Court Reinstates Hundreds of Incretin Mimetics Cases

November 2017 — The 9th Circuit of U.S. Court of Appeals returned the decision that the district court had misapplied the Supreme Court case Buckman Co. v Plaintiffs’ Legal Committee.  They ruled that the case had been misapplied in two ways.  The first was the district court relying on Buckman to impermissibly circumscribe discovery.  The second was the court...

Continue Reading

| Read Time: 2 minutes | Car Accident

Go With Experience

If you are searching for legal counsel in Evansville, Indianapolis, Louisville, Owensboro, or surrounding communities, contact Gerling Law. Our lawyers have one purpose: to make your life better through assertive advocacy, legal experience, and a commitment to results. For over five decades, our firm has helped individuals get their lives back after an accident or when they can no...

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Sanofi’s Motion to Dismiss Denied

September 2017 — The Court denied Sanofi’s motion to dismiss all counts. Reference: “Taxotere Lawsuit – Permanent Hair Loss and Illegal Marketing.” Drugwatch.com, 20 Apr. 2020, www.drugwatch.com/taxotere/lawsuits/

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Study Shows Ranitidine Leads To High NDMA Levels

2016 — A Mitch study in 2016 tested urine samples of 10 people, 5 males and 5 females, who took a single 150 mg ranitidine tablet.  They found NDMA levels higher than the FDA limits.  Their urine was tested 24 hours before taking ranitidine and then 24 hours after.  The study found that the levels of NDMA in the...

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Doctor’s Research Aiding Investigation Of Link Between Incretin Mimetics and Cancer

A previous Merck researcher is now assisting litigation against such drug manufacturers over diabetes treatments that he found were linked to pancreatic cancer. Dr. Peter Butler tested Merck’s drug Januvia on rats in 2008 and discovered changes in the rats’ pancreases that he worried could lead to cancer. Butler’s follow-up research to confirm the linkage is now fueling investigations...

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

GlaxoKlineSmith Ranitidine Patent Expires

1997 — In 1997, GlaxoKlineSmith’s U.S. patent for ranitidine expired.  Competitors were now able to create generic alternatives. Reference:  “Timeline: Popular Heartburn Medicine Zantac Pulled off Store Shelves.” Reuters, Thomson Reuters, 21 Oct. 2019, www.reuters.com/article/us-health-fda-heartburn-timeline/timeline-popular-heartburn-medicine-zantac-pulled-off-store-shelves-idUSKBN1X014E.

Continue Reading

| Read Time: < 1 minute | Dangerous Drugs

Zantac Experiences Exponential Growth

1988 — In 1988, Zantac became the world’s best selling drug and one of the first drugs to ever top $1 billion in annual sales. Reference:  “Timeline: Popular Heartburn Medicine Zantac Pulled off Store Shelves.” Reuters, Thomson Reuters, 21 Oct. 2019, www.reuters.com/article/us-health-fda-heartburn-timeline/timeline-popular-heartburn-medicine-zantac-pulled-off-store-shelves-idUSKBN1X014E.

Continue Reading